Compare · PM vs TLRY
PM vs TLRY
Side-by-side comparison of Philip Morris International Inc (PM) and Tilray Brands Inc. (TLRY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PM and TLRY operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- PM is the larger of the two at $291.93B, about 548.2x TLRY ($532.5M).
- TLRY has been more active in the news (16 items in the past 4 weeks vs 6 for PM).
- PM has more recent analyst coverage (25 ratings vs 14 for TLRY).
- Company
- Philip Morris International Inc
- Tilray Brands Inc.
- Price
- $188.33+0.44%
- $4.51-1.20%
- Market cap
- $291.93B
- $532.5M
- 1M return
- +0.49%
- -
- 1Y return
- +12.53%
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NYSE
- NASDAQ
- IPO
- 2018
- News (4w)
- 6
- 16
- Recent ratings
- 25
- 14
Philip Morris International Inc
Philip Morris International Inc., through its subsidiaries, manufactures and sells cigarettes, other nicotine-containing products, smoke-free products, and related electronic devices and accessories. The company offers IQOS smoke-free products, including heated tobacco and nicotine-containing vapor products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, and Parliament HeatSticks brands, as well as under the Fiit and Miix licensed brands. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. It markets and sells its products in the European Union, Eastern Europe, the Middle East, Africa, South and Southeast Asia, East Asia, Australia, Latin America, and Canada. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.
Tilray Brands Inc.
Tilray, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. The company operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. It provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. The company offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Aphria Inc. Tilray, Inc. was incorporated in 2018 and is based in New York, New York.
Latest PM
- Philip Morris International to Host Webcast of Fireside Chat Session at Barclays Global Consumer Conference
- Philip Morris International Inc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Altria Announces Arrangement with Philip Morris International to Enhance Operational Efficiency
- Philip Morris International Announces Contract Manufacturing Collaboration with Altria
- FDA Authorizes ZYN ULTRA Nicotine Pouches Following Scientific Review
- PMI U.S. Names Five Artists Shaping Modern American Culture for the ZYN America250 Art Series
- New insider Andolina Massimo claimed ownership of 71,588 shares (SEC Form 3)
- SEC Form 25-NSE filed by Philip Morris International Inc
- SEC Form 10-Q filed by Philip Morris International Inc
- BTIG Research initiated coverage on Philip Morris International with a new price target
Latest TLRY
- Award-Winning BrewDog Unleashes Liquid Visions, a Bold New Craft Beer Series Built to Light Up Retail Shelves
- President and CEO Simon Irwin D converted options into 1,212,168 shares and covered exercise/tax liability with 642,450 shares, increasing direct ownership by 77% to 1,309,031 units (SEC Form 4) to satisfy tax liability
- Chief Financial Officer Merton Carl A converted options into 168,452 shares and covered exercise/tax liability with 92,649 shares, increasing direct ownership by 54% to 215,556 units (SEC Form 4) (tax liability)
- Global General Counsel Gendel Mitchell converted options into 160,304 shares and covered exercise/tax liability with 84,962 shares, increasing direct ownership by 60% to 200,225 units (SEC Form 4) to cover taxes
- Chief Strategy Officer Faltischek Denise M converted options into 178,221 shares and covered exercise/tax liability with 94,459 shares, increasing direct ownership by 59% to 225,047 units (SEC Form 4) (tax withholding)
- BrewDog Wins Big at the 2026 World Beer Awards with a Sweeping Show of Brewing Excellence
- Tilray Strengthens Global Medical Cannabis Leadership with Major Production Increase to Meet International Demand
- BrewDog Unwraps Its 2026 Advent Calendar
- Tilray Medical Welcomes Progress in Germany’s Medical Cannabis Framework and Supports Continued Policy Development
- Montauk Brewing Company Expands Its Coastal Footprint with New North Shore Brewpub